Humanoid Robot Wins Beijing Half-Marathon, Beats Human World Record
A humanoid robot won a half-marathon race for robots in Beijing, completing the course faster than the human world record, marking a significant technological milestone.
Key Points
- Robot completed half-marathon faster than human world record
- Event shows significant progress from previous year's race
- Part of China's 2026-2030 plan to develop humanoid robotics
Full Details
A humanoid robot has won a half-marathon race specifically for robots in Beijing, running the course faster than the current human world record. The performance represents a major leap forward from the previous year's inaugural race, where the winning robot finished in 2 hours, 40 minutes, and 42 seconds. According to state media outlet Global Times, a separate, remotely-controlled robot from Honor was the first to cross the finish line in 48 minutes and 19 seconds. This achievement is part of China's broader technological ambitions, as outlined in its latest five-year plan which targets the frontiers of science and technology. The plan specifically aims to accelerate the development of products like humanoid robots and their applications for the 2026-2030 period.
Why It Matters
This breakthrough demonstrates China's accelerating advancement in robotics, potentially reshaping future athletic competitions and labor industries.
Get stories like this delivered daily
AI-curated news, personalized to your interests. Zero noise.
Start 7-Day Free Trial →More in Artificial Intelligence
Nvidia AI Chip Rivals Attract Record Funding as Competition Intensifies
Emerging AI chip startups challenging Nvidia's dominance are attracting unprecedented levels of investment as competition heats up in the semiconductor sector.
Cursor AI Startup in Talks for $2 Billion Funding at $50 Billion Valuation
AI coding-agent startup Cursor is negotiating a $2 billion funding round at a valuation exceeding $50 billion, highlighting intense venture capital interest in AI development tools.
Yann LeCun's AMI Labs Secures Over $1 Billion for AI World Models Development
AMI Labs, founded by AI pioneer Yann LeCun, has raised more than $1 billion to develop 'world models' - a new AI approach that teaches systems to understand inputs conceptually rather than as isolated components.
AI Revolutionizes Drug Target Identification and Assessment in Pharmaceutical Research
Artificial intelligence is playing an increasingly critical role in drug target identification and assessment, with new machine learning approaches transforming how researchers discover therapeutic targets for diseases including cancer, aging, and Alzheimer's.